Stomatology ›› 2023, Vol. 43 ›› Issue (7): 652-656.doi: 10.13591/j.cnki.kqyx.2023.07.013
• Summary • Previous Articles Next Articles
Revised:
2022-12-20
Online:
2023-07-28
Published:
2023-07-28
CLC Number:
LI Shaohua, LIN Xiaoping. Research progress of the relationship between periodontitis and non-alcoholic fatty liver disease[J]. Stomatology, 2023, 43(7): 652-656.
[1] |
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J]. J Hepatol, 2016, 64(6):1388-1402.
doi: 10.1016/j.jhep.2015.11.004 pmid: 27062661 |
[2] | Liu JY, Tian Y, Fu X, et al. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: Systematic review and meta-analysis[J]. Chin Med J (Engl), 2022, 135(14):1682-1691. |
[3] |
Tan DJH, Ng CH, Lin SY, et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis[J]. Lancet Oncol, 2022, 23(4):521-530.
doi: 10.1016/S1470-2045(22)00078-X pmid: 35255263 |
[4] |
Weintraub JA, Lopez Mitnik G, Dye BA. Oral diseases associated with nonalcoholic fatty liver disease in the United States[J]. J Dent Res, 2019, 98(11):1219-1226.
doi: 10.1177/0022034519866442 pmid: 31369716 |
[5] |
Iwasaki T, Hirose A, Azuma T, et al. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan[J]. Sci Rep, 2018, 8(1):7496.
doi: 10.1038/s41598-018-25857-z pmid: 29760403 |
[6] |
Helenius-Hietala J, Suominen AL, Ruokonen H, et al. Periodontitis is associated with incident chronic liver disease-A population-based cohort study[J]. Liver Int, 2019, 39(3):583-591.
doi: 10.1111/liv.13985 pmid: 30300961 |
[7] |
Shin HS. Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study[J]. J Periodontol, 2020, 91(4):524-532.
doi: 10.1002/jper.v91.4 |
[8] |
Kim JY, Lee GN, Song HC, et al. Association between fatty liver index and periodontitis: The Korea national health and nutrition examination survey[J]. Sci Rep, 2020, 10(1):3805.
doi: 10.1038/s41598-020-60797-7 |
[9] |
Surlin P, Didilescu AC, Lazar L, et al. Evaluation through the optical coherence tomography analysis of the influence of non-alcoholic fatty liver disease on the gingival inflammation in periodontal patients[J]. Diabetes Metab Syndr Obes, 2021, 14:2935-2942.
doi: 10.2147/DMSO.S310314 |
[10] |
Alazawi W, Bernabe E, Tai D, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease[J]. PLoS One, 2017, 12(12):e0185902.
doi: 10.1371/journal.pone.0185902 |
[11] |
Kuroe K, Furuta M, Takeuchi K, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults[J]. J Clin Periodontol, 2021, 48(3):368-377.
doi: 10.1111/jcpe.13415 pmid: 33368494 |
[12] |
Cecil JD, Sirisaengtaksin N, O'brien-Simpson NM, et al. Outer membrane vesicle-host cell interactions[J]. Microbiol Spectr, 2019, 7(1):10.1128/microbiolspec.PSIB-10.1128/microbiolspec.0001-2018.
doi: 10.1128/microbiolspec.PSIB-10.1128/microbiolspec.0001-2018 |
[13] |
Seyama M, Yoshida K, Yoshida K, et al. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(6):165731.
doi: 10.1016/j.bbadis.2020.165731 |
[14] |
Yue YY, Liu XC, Li Y, et al. The role of TLR4/MyD88/NF-κB pathway in periodontitis-induced liver inflammation of rats[J]. Oral Dis, 2021, 27(4):1012-1021.
doi: 10.1111/odi.v27.4 |
[15] |
Ding LY, Liang LZ, Zhao YX, et al. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways[J]. Oral Dis, 2019, 25(7):1789-1797.
doi: 10.1111/odi.v25.7 |
[16] | Cai J, Chen JM, Guo HX, et al. Recombinant fimbriae protein of Porphyromonas gingivalis induces an inflammatory response via the TLR4/NF-κB signaling pathway in human peripheral blood mononuclear cells[J]. Int J Mol Med, 2019, 43(3):1430-1440. |
[17] |
Qiao WW, Wang CN, Huang WS, et al. Peroxisome proliferator-activated receptor γ plays dual roles on experimental periodontitis in rats[J]. J Clin Periodontol, 2018, 45(5):514-523.
doi: 10.1111/jcpe.12891 pmid: 29574908 |
[18] | Lu Z, Li Y, Yu H, et al. High-fat diet-induced metabolic syndrome increases ligature-induced alveolar bone loss in mice[J]. Oral Dis, 2021:2021Dec16. |
[19] |
Karunakaran U, Elumalai S, Moon JS, et al. CD36 signal transduction in metabolic diseases: Novel insights and therapeutic targeting[J]. Cells, 2021, 10(7):1833.
doi: 10.3390/cells10071833 |
[20] | Yang Z, Huang XP, Zhang JY, et al. Hepatic DKK1-driven steatosis is CD36 dependent[J]. Life Sci Alliance, 2022, 6(1):e202201665. |
[21] |
Zhang C, Luo XH, Chen JR, et al. Osteoprotegerin promotes liver steatosis by targeting the ERK-PPAR-γ-CD36 pathway[J]. Diabetes, 2019, 68(10):1902-1914.
doi: 10.2337/db18-1055 pmid: 31292134 |
[22] |
Hajri T, Zaiou M, Fungwe TV, et al. Epigenetic regulation of peroxisome proliferator-activated receptor gamma mediates high-fat diet-induced non-alcoholic fatty liver disease[J]. Cells, 2021, 10(6):1355.
doi: 10.3390/cells10061355 |
[23] |
Ahn JS, Yang JW, Oh SJ, et al. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway[J]. BMB Rep, 2021, 54(6):323-328.
doi: 10.5483/BMBRep.2021.54.6.050 |
[24] |
Ni J, Chen L, Zhong SL, et al. Influence of periodontitis and scaling and root planing on insulin resistance and hepatic CD36 in obese rats[J]. J Periodontol, 2018, 89(4):476-485.
doi: 10.1002/JPER.17-0115 pmid: 29520779 |
[25] |
Vasconcelos ACCG, Vasconcelos DFP, Pereira da Silva FR, et al. Periodontitis causes abnormalities in the liver of rats[J]. J Periodontol, 2019, 90(3):295-305.
doi: 10.1002/JPER.18-0226 pmid: 30216457 |
[26] |
Mester A, Ciobanu L, Taulescu M, et al. Periodontal disease may induce liver fibrosis in an experimental study on Wistar rats[J]. J Periodontol, 2019, 90(8):911-919.
doi: 10.1002/JPER.18-0585 pmid: 30689209 |
[27] |
dos Santos Carvalho J, Cardoso Guimarães Vasconcelos AC, Herlany Pereira Alves E, et al. Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats[J]. J Periodontal Res, 2017, 52(5):883-892.
doi: 10.1111/jre.12459 pmid: 28504459 |
[28] |
Andrade RSB, França LFC, Pessoa LDS, et al. High-fat diet aggravates the liver disease caused by periodontitis in rats[J]. J Periodontol, 2019, 90(9):1023-1031.
doi: 10.1002/JPER.18-0564 pmid: 30801719 |
[29] |
Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice[J]. J Gastroenterol, 2013, 48(11):1259-1270.
doi: 10.1007/s00535-012-0738-1 pmid: 23307045 |
[30] |
Zhu XP, Bian H, Wang L, et al. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway[J]. Free Radic Biol Med, 2019, 141:192-204.
doi: 10.1016/j.freeradbiomed.2019.06.019 |
[31] |
Xing T, Liu YJ, Cheng HX, et al. Ligature induced periodontitis in rats causes gut dysbiosis leading to hepatic injury through SCD1/AMPK signalling pathway[J]. Life Sci, 2022, 288:120162.
doi: 10.1016/j.lfs.2021.120162 |
[32] |
Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by Porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice[J]. Front Microbiol, 2018, 9:2470.
doi: 10.3389/fmicb.2018.02470 pmid: 30405551 |
[33] |
Jiang PR, Zheng WY, Sun XN, et al. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-induced metabolic syndrome, gut microbiota dysbiosis and inflammation in BALB/c mice[J]. Int J Biol Macromol, 2021, 167:1587-1597.
doi: 10.1016/j.ijbiomac.2020.11.116 |
[34] |
Symmank J, Appel S, Bastian JA, et al. Hyperlipidemic conditi-ons impact force-induced inflammatory response of human periodontal ligament fibroblasts concomitantly challenged with P. gingivalis-LPS[J]. Int J Mol Sci, 2021, 22(11):6069.
doi: 10.3390/ijms22116069 |
[35] |
Nagasaki A, Sakamoto S, Arai T, et al. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH[J]. J Clin Periodontol, 2021, 48(10):1367-1378.
doi: 10.1111/jcpe.v48.10 |
[36] |
Kamata Y, Kessoku T, Shimizu T, et al. Efficacy and safety of PERIO dontal treatment versus usual care for Nonalcoholic liver disease: Protocol of the PERION multicenter, two-arm, open-label, randomized trial[J]. Trials, 2020, 21(1):291.
doi: 10.1186/s13063-020-4201-y pmid: 32293522 |
[37] | 柴红波, 梁守建, 牛玉明, 等. 大黄素下调牙周组织细胞核因子-κB是治疗中、重度慢性牙周炎机制之一[J]. 实用口腔医学杂志, 2020, 36(3):517-520. |
[38] | 谷冬华, 郭宁, 赵晓丹, 等. 联用大黄、黄芩对牙周炎SD大鼠炎性因子的抑制作用及对骨组织再生的促进效应研究[J]. 口腔医学, 2020, 40(8):692-697. |
[39] | 王玉, 杨雪, 夏鹏飞, 等. 大黄化学成分、药理作用研究进展及质量标志物的预测分析[J]. 中草药, 2019, 50(19):4821-4837. |
[40] | 崔祥, 陶金华, 江曙, 等. 小檗碱与肠道菌群的相互作用研究[J]. 中国微生态学杂志, 2017, 29(12):1373-1377. |
[41] | 吴松, 张文娟, 崔茸茸, 等. 小檗碱对牙周炎大鼠的细胞因子水平、氧化应激和炎症性骨溶解的实验研究[J]. 现代生物医学进展, 2022, 22(5):814-817, 851. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||